Difference between revisions of "Post-tPA Hemorrhage in CVA"

(Text replacement - "==References== " to "==References== <references/> ")
Line 1: Line 1:
 
==Background==
 
==Background==
*Consider if patient develops:
+
*Consider post-tPA [[ICH]] if patient develops:
**Decreased LOC
+
**[[AMS|Decreased LOC]]
**Increased weakness
+
**Increased [[weakness]]
**New headache
+
**New [[headache]]
**Sudden rise in BP
+
**Sudden rise in [[hypertension|BP]]
 +
*May also have [[GI bleed]], mucosal bleeding
  
 
==Management==
 
==Management==
 
*Stop tPA
 
*Stop tPA
*Head CT
+
*[[Head CT]]
 
**If no bleeding: resume tPA
 
**If no bleeding: resume tPA
 
**If bleeding:
 
**If bleeding:
 
***Consider fibrinogen replacement  
 
***Consider fibrinogen replacement  
 
***Recheck CBC, coags fibrinogen levels
 
***Recheck CBC, coags fibrinogen levels
***Prepare 6-8 units cryoprecipitate
+
***Prepare 6-8 units [[cryoprecipitate]]
***Prepare 6-8 units platelets
+
***Prepare 6-8 units [[platelets]]
  
 
==See Also==
 
==See Also==
Line 23: Line 24:
 
<references/>
 
<references/>
 
[[Category:Neurology]]
 
[[Category:Neurology]]
 +
[[Category:Critical Care]]

Revision as of 04:30, 3 October 2019

Background

Management

  • Stop tPA
  • Head CT
    • If no bleeding: resume tPA
    • If bleeding:
      • Consider fibrinogen replacement
      • Recheck CBC, coags fibrinogen levels
      • Prepare 6-8 units cryoprecipitate
      • Prepare 6-8 units platelets

See Also

References